662 related articles for article (PubMed ID: 19172543)
1. Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations.
Lello S; Primavera G; Colonna L; Vittori G; Guardianelli F; Sorge R; Raskovic D
Gynecol Endocrinol; 2008 Dec; 24(12):718-23. PubMed ID: 19172543
[TBL] [Abstract][Full Text] [Related]
2. [Effect on skin and hormonal hyperandrogenic manifestations of an oral estroprogestin association containing ethynilestradiol 30 mg and drospirenone 3 mg].
Lello S; Primavera G; Colonna L; Vittori G; Guardianelli F; Pallotta P; Sorge R; Bilchugova E; Raskovic D
Minerva Ginecol; 2008 Jun; 60(3):239-43. PubMed ID: 18547986
[TBL] [Abstract][Full Text] [Related]
3. The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.
van Vloten WA; van Haselen CW; van Zuuren EJ; Gerlinger C; Heithecker R
Cutis; 2002 Apr; 69(4 Suppl):2-15. PubMed ID: 12096825
[TBL] [Abstract][Full Text] [Related]
4. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
Palatsi R; Reinilä M; Kivinén S
Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hirsutism with combined pill containing drospirenone.
Gregoriou O; Papadias K; Konidaris S; Bakalianou K; Salakos N; Vrachnis N; Creatsas G
Gynecol Endocrinol; 2008 Apr; 24(4):220-3. PubMed ID: 18382909
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
[TBL] [Abstract][Full Text] [Related]
7. Hyperandrogenic women treated with a continuous-regimen oral contraceptive.
Caruso S; Cianci S; Malandrino C; Cicero C; Lo Presti L; Cianci A
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):307-10. PubMed ID: 24183349
[TBL] [Abstract][Full Text] [Related]
8. Skin improvement with two different oestroprogestins in patients affected by acne and polycystic ovary syndrome: clinical and instrumental evaluation.
Colonna L; Pacifico V; Lello S; Sorge R; Raskovic D; Primavera G
J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1364-71. PubMed ID: 22011217
[TBL] [Abstract][Full Text] [Related]
9. Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.
De Leo V; Di Sabatino A; Musacchio MC; Morgante G; Scolaro V; Cianci A; Petraglia F
Contraception; 2010 Sep; 82(3):276-80. PubMed ID: 20705157
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial.
Plewig G; Cunliffe WJ; Binder N; Höschen K
Contraception; 2009 Jul; 80(1):25-33. PubMed ID: 19501212
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism.
Batukan C; Muderris II
Fertil Steril; 2006 Feb; 85(2):436-40. PubMed ID: 16595223
[TBL] [Abstract][Full Text] [Related]
12. Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris.
Mango D; Ricci S; Manna P; Miggiano GA; Serra GB
Contraception; 1996 Mar; 53(3):163-70. PubMed ID: 8689881
[TBL] [Abstract][Full Text] [Related]
13. Effect of chlormadinone acetate versus drospirenone-containing oral contraceptives on the endocrinal features of women with polycystic ovary syndrome: Systematic review and meta-analysis of randomized clinical trials.
Menshawy A; Ismail A; Abdel-Maboud M; El-Din AA; Elgebaly A; Gadelkarim M; Bahbah EI; Abdelghany MF; Samy A; Abbas AM
J Gynecol Obstet Hum Reprod; 2019 Nov; 48(9):763-770. PubMed ID: 30940512
[TBL] [Abstract][Full Text] [Related]
14. Endocrine parameters in acne vulgaris.
Schmidt JB; Lindmaier A; Spona J
Endocrinol Exp; 1990 Dec; 24(4):457-64. PubMed ID: 2151388
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of different antiandrogenic progestins on clinical and biochemical variables in polycystic ovary syndrome.
Morgante G; Cappelli V; Troìa L; De Leo V
Eur J Contracept Reprod Health Care; 2020 Jun; 25(3):176-181. PubMed ID: 32191532
[No Abstract] [Full Text] [Related]
16. Androgen excess in cystic acne.
Marynick SP; Chakmakjian ZH; McCaffree DL; Herndon JH
N Engl J Med; 1983 Apr; 308(17):981-6. PubMed ID: 6220224
[TBL] [Abstract][Full Text] [Related]
17. SHBG, testosterone, androstenedione, 17-OH-Progesterone plasma levels in PCO affected women treated with a triphasic oral contraceptive.
Negri P; Agnello G; Borghesani F; Tomain L; Minisci N; D'Errico G; Cavallini AR
Acta Eur Fertil; 1987; 18(6):375-80. PubMed ID: 3454501
[TBL] [Abstract][Full Text] [Related]
18. Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives.
Palatsi R; Hirvensalo E; Liukko P; Malmiharju T; Mattila L; Riihiluoma P; Ylöstalo P
Acta Derm Venereol; 1984; 64(6):517-23. PubMed ID: 6084924
[TBL] [Abstract][Full Text] [Related]
19. Quality of sexual life in hyperandrogenic women treated with an oral contraceptive containing chlormadinone acetate.
Caruso S; Rugolo S; Agnello C; Romano M; Cianci A
J Sex Med; 2009 Dec; 6(12):3376-84. PubMed ID: 19832931
[TBL] [Abstract][Full Text] [Related]
20. Do some men with acne vulgaris have raised levels of LH?
Farrell A; Alaghband-Zadeh J; Carter G; Newson RB; Cream JJ
Clin Endocrinol (Oxf); 1999 Mar; 50(3):393-7. PubMed ID: 10435067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
